191 related articles for article (PubMed ID: 37605516)
1. Histologic heterogeneity predicts patient prognosis of HER2-positive metastatic breast cancer: A retrospective study based on SEER database.
Wang Y; Liang Y; Ye F; Luo D; Jin Y; Li Y; Zhao W; Chen B; Wang L; Yang Q
Cancer Med; 2023 Sep; 12(18):18597-18610. PubMed ID: 37605516
[TBL] [Abstract][Full Text] [Related]
2. The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast.
Zhao H
Breast Cancer; 2021 Jan; 28(1):187-195. PubMed ID: 32812198
[TBL] [Abstract][Full Text] [Related]
3. Specific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancer.
Inoue M; Nakagomi H; Nakada H; Furuya K; Ikegame K; Watanabe H; Omata M; Oyama T
Breast Cancer; 2017 Sep; 24(5):667-672. PubMed ID: 28108967
[TBL] [Abstract][Full Text] [Related]
4. Impact of histotypes on preferential organ-specific metastasis in triple-negative breast cancer.
Li Y; Su P; Wang Y; Zhang H; Liang Y; Zhang N; Song X; Li X; Li J; Yang Q
Cancer Med; 2020 Feb; 9(3):872-881. PubMed ID: 31814295
[TBL] [Abstract][Full Text] [Related]
5. Impact of lobular versus ductal histology on overall survival in metastatic breast cancer: a French retrospective multicentre cohort study.
Dalenc F; Lusque A; De La Motte Rouge T; Pistilli B; Brain E; Pasquier D; Debled M; Thery JC; Gonçalves A; Desmoulins I; Levy C; Uwer L; Ferrero JM; Eymard JC; Mouret-Reynier MA; Patsouris A; Frenel JS; Petit T; Chevrot M; Bachelot T; Guiu S
Eur J Cancer; 2022 Mar; 164():70-79. PubMed ID: 35176614
[TBL] [Abstract][Full Text] [Related]
6. Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010-2014.
Schroeder MC; Rastogi P; Geyer CE; Miller LD; Thomas A
Oncologist; 2018 Apr; 23(4):481-488. PubMed ID: 29330212
[TBL] [Abstract][Full Text] [Related]
7. Patient treatment and outcome after breast cancer orbital and periorbital metastases: a comprehensive case series including analysis of lobular versus ductal tumor histology.
Blohmer M; Zhu L; Atkinson JM; Beriwal S; Rodríguez-López JL; Rosenzweig M; Brufsky AM; Tseng G; Lucas PC; Lee AV; Oesterreich S; Jankowitz RC
Breast Cancer Res; 2020 Jun; 22(1):70. PubMed ID: 32586354
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer bone metastases at initial diagnosis: a SEER-based study.
Li X; Zhang X; Liu J; Shen Y
BMC Cancer; 2020 Nov; 20(1):1102. PubMed ID: 33187507
[TBL] [Abstract][Full Text] [Related]
9. Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade.
Metzger-Filho O; Ferreira AR; Jeselsohn R; Barry WT; Dillon DA; Brock JE; Vaz-Luis I; Hughes ME; Winer EP; Lin NU
Oncologist; 2019 Jul; 24(7):e441-e449. PubMed ID: 30518616
[TBL] [Abstract][Full Text] [Related]
10. Invasive lobular carcinoma of the breast: A special histological type compared with invasive ductal carcinoma.
Chen Z; Yang J; Li S; Lv M; Shen Y; Wang B; Li P; Yi M; Zhao X; Zhang L; Wang L; Yang J
PLoS One; 2017; 12(9):e0182397. PubMed ID: 28863134
[TBL] [Abstract][Full Text] [Related]
11. Strong adverse effect of epidermal growth factor receptor 2 overexpression on prognosis of patients with invasive lobular breast cancer: a comparative study with invasive ductal breast cancer in Chinese population.
Wang T; Ma Y; Wang L; Liu H; Chen M; Niu R
Tumour Biol; 2015 Aug; 36(8):6113-24. PubMed ID: 25804795
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study.
Wu Q; Li J; Zhu S; Wu J; Chen C; Liu Q; Wei W; Zhang Y; Sun S
Oncotarget; 2017 Apr; 8(17):27990-27996. PubMed ID: 28427196
[TBL] [Abstract][Full Text] [Related]
13. HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular Insights.
Da Ros L; Moretti A; Querzoli P; Pedriali M; Lupini L; Bassi C; Carcoforo P; Negrini M; Frassoldati A
Clin Breast Cancer; 2018 Oct; 18(5):e1133-e1139. PubMed ID: 29759595
[TBL] [Abstract][Full Text] [Related]
14. Biomarker profile of invasive lobular carcinoma: pleomorphic versus classic subtypes, clinicopathological characteristics and prognosis analyses.
Zhang Y; Luo X; Chen M; Yang L; Lei T; Pu T; Wei B; Bu H; Zhang Z
Breast Cancer Res Treat; 2022 Jul; 194(2):279-295. PubMed ID: 35666367
[TBL] [Abstract][Full Text] [Related]
15. The effect of metastasis patterns on survival in male patients with different breast cancer subtypes: results from the Surveillance, Epidemiology, and End Results (SEER) database.
Zhou W; Wang SP; Zeng W; Chen SC; Huang YH; Zhou L; Wang M; Wei W; Zhang C; Liu ZM; Guo L
Transl Cancer Res; 2020 Apr; 9(4):2267-2279. PubMed ID: 35117587
[TBL] [Abstract][Full Text] [Related]
16. Overall Survival of Men and Women With Breast Cancer According to Tumor Subtype: A Population-based Study.
Leone J; Zwenger AO; Leone BA; Vallejo CT; Leone JP
Am J Clin Oncol; 2019 Feb; 42(2):215-220. PubMed ID: 30499840
[TBL] [Abstract][Full Text] [Related]
17. Metastasis patterns and prognosis of octogenarians with metastatic breast cancer: A large-cohort retrospective study.
Lv Z; Zhang W; Zhang Y; Zhong G; Zhang X; Yang Q; Li Y
PLoS One; 2022; 17(2):e0263104. PubMed ID: 35176034
[TBL] [Abstract][Full Text] [Related]
18. Hormone receptor status does not affect prognosis in metaplastic breast cancer: a population-based analysis with comparison to infiltrating ductal and lobular carcinomas.
Paul Wright G; Davis AT; Koehler TJ; Melnik MK; Chung MH
Ann Surg Oncol; 2014 Oct; 21(11):3497-503. PubMed ID: 24838367
[TBL] [Abstract][Full Text] [Related]
19. Risk and prognostic factors of breast cancer with liver metastases.
Ji L; Cheng L; Zhu X; Gao Y; Fan L; Wang Z
BMC Cancer; 2021 Mar; 21(1):238. PubMed ID: 33676449
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the clinicopathological features of invasive ductal, invasive lobular, and mixed (invasive ductal + invasive lobular) carcinoma of the breast.
Zengel B; Yararbas U; Duran A; Uslu A; Elıyatkın N; Demırkıran MA; Cengiz F; Şimşek C; Postacı H; Vardar E; Durusoy R
Breast Cancer; 2015 Jul; 22(4):374-81. PubMed ID: 23925582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
